Yuka Kitajima

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders".

Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders".

Journal: Parkinson's disease

Published: May 07, 2016

Assessment of Cognitive Dysfunction Caused by Anticholinergic Burden in Japanese Alzheimer's Disease Patients, Using the Most Commonly Used Scales in Japan.

Assessment of Cognitive Dysfunction Caused by Anticholinergic Burden in Japanese Alzheimer's Disease Patients, Using the Most Commonly Used Scales in Japan.

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology

Published: January 21, 2016

A Review of the Role of Anticholinergic Activity in Lewy Body Disease and Delirium.

A Review of the Role of Anticholinergic Activity in Lewy Body Disease and Delirium.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Plasma Cholinesterase Activity in Alzheimer's Disease.

Plasma Cholinesterase Activity in Alzheimer's Disease.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Anticholinergic Activity and Schizophrenia.

Anticholinergic Activity and Schizophrenia.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease.

Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Demonstrating the Role of Anticholinergic Activity in a Mood Disorder.

Demonstrating the Role of Anticholinergic Activity in a Mood Disorder.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity.

Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease.

Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease.

Journal: Neuro-degenerative diseases

Published: July 04, 2015

Proposal of endogenous anticholinergic hypothesis in Alzheimer disease

Proposal of endogenous anticholinergic hypothesis in Alzheimer disease

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology

Published: July 30, 2014

Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease.

Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease.

Journal: Disease markers

Published: October 15, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026